Oral supplementation of turmeric decreases proteinuria, hematuria, and systolic blood pressure in patients suffering from relapsing or refractory lupus nephritis: a randomized and placebo-controlled study.

16 Apr 2012Khajehdehi P, Zanjaninejad B, Aflaki E, Nazarinia M, Azad F, Malekmakan L, Dehghanzadeh GR.

Short-term turmeric supplementation can decrease proteinuria, hematuria, and systolic blood pressure in patients suffering from relapsing or refractory lupus nephritis and can be used as an adjuvant safe therapy for such patients.

Randomized Controlled Trial
5 effects
3 months
24 subjects

Reported Outcomes

DeterminantsOutcomeDetails

Curcumin (Turmeric) Herb risk & protective factor
Minor Protective Factor Curcumin (Turmeric)
Herb

Inflammation Lymphatic outcome
Minor decreased risk of Inflammation
Lymphatic system

Low evidence
-1.0%

Curcumin (Turmeric) Herb risk & protective factor
Minor Protective Factor Curcumin (Turmeric)
Herb

Type 2 Diabetes Lymphatic outcome
Minor decreased risk of Type 2 Diabetes
Lymphatic system

Low evidence
-1.0%

Curcumin (Turmeric) Herb risk & protective factor
Minor Protective Factor Curcumin (Turmeric)
Herb

Blood Pressure - Hypertension Cardiovascular outcome
Minor decreased risk of Blood Pressure - Hype...
Cardiovascular system

Moderate evidence
-12.0%

Curcumin (Turmeric) Herb risk & protective factor
Protective Factor Curcumin (Turmeric)
Herb

Kidney Damage (Proteinuria) Urinary outcome
Decreased risk of Kidney Damage (Protei...
Urinary system

Moderate evidence
-266.0%

Curcumin (Turmeric) Herb risk & protective factor
Minor Protective Factor Curcumin (Turmeric)
Herb

Oxidative stress Lymphatic outcome
Minor decreased risk of Oxidative stress
Lymphatic system

Low evidence
-1.0%